Levetiracetam-d3

• CAT Number: R006085
• CAS Number: 1217851-16-5
• Molecular Formula: C8H14N2O2
• Molecular Weight: 173.23
• Purity: ≥95%
• Synonyms: (αS)-α-(Ethyl-d3)-2-oxo-1-pyrrolidineacetamide; (-)-Levetiracetam-d3; Keppra-d3; Levesam 500-d3; UCB-L 059-d3
• Storage: Room temperature
• IUPAC Name: (2S)-4,4,4-trideuterio-2-(2-oxopyrrolidin-1-yl)butanamide
• InChI: InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1/i1D3
• InChIKey: HPHUVLMMVZITSG-FYFSCIFKSA-N
• SMILES: [2H]C([2H])([2H])C[C@@H](C(=O)N)N1CCCC1=O

Levetiracetam-d3 is a deuterated form of levetiracetam, a widely used antiepileptic drug, where three hydrogen atoms are replaced with deuterium. This modification makes it an essential internal standard in analytical methods such as mass spectrometry and NMR spectroscopy, ensuring precise quantification and structural analysis. In pharmaceutical chemistry, it supports drug metabolism and pharmacokinetic studies, helping to understand levetiracetam’s behavior in biological systems. In organic chemistry, it is employed in reaction mechanism investigations and isotope dilution assays. Its deuterium labeling enhances the accuracy of analytical techniques, making it crucial for high-precision research and development in various scientific fields.